Abaxis (ABAX) Tops Q4 EPS by 23c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2015 and Declares a 10% Increase in Quarterly Cash Dividend
April 30, 2015 4:00 PM EDTUNION CITY, Calif., April 30, 2015 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today reported financial results for the fourth quarter and fiscal year ended March 31, 2015.
Fourth quarter and fiscal 2015 overview:
Revenues from continuing operations of $52.0 million for the fourth quarter, up 33% over last year's comparable quarter, and $202.6 million for fiscal 2015, up 25% year-over-year. Diluted EPS of $0.50 for the fourth quarter, up 194% over last year's comparable quarter, and $1.20 for fiscal 2015, up 90% year-over-year. Diluted EPS... MoreAbaxis Reconfigures Executive Management Team
April 30, 2015 8:01 AM EDTUNION CITY, Calif., April 30, 2015 /PRNewswire/ --Â Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care instruments and consumables for the medical, research, and veterinary markets worldwide, announced today changes to its executive management team.
Mr. Alberto "Al" Santa Ines, 68, chief financial officer and vice president of finance of Abaxis for the past 15 years will retire effective July 31, 2015. Mr. Ross Taylor, currently the Company's vice president of business development and investor relations, will transition into the roles of chief financial officer and vice president of... More
